Perrigo Company plc's (NYSE: PRGO ) HRA Pharma has submitted its application to the FDA for the first-ever over-the-counter (OTC) birth control pill, the first such request for this type of contraception.
The product has been sold as a prescription drug as Opill since 1973, a progestin-only daily birth control pill (also referred to as a mini pill or non-estrogen pill).
The application comes on the back of the U.S. Supreme Court's decision in ...
Full story available on Benzinga.com